Your browser doesn't support javascript.
loading
Neratinib-Plus-Cetuximab in Quadruple-WT (KRAS, NRAS, BRAF, PIK3CA) Metastatic Colorectal Cancer Resistant to Cetuximab or Panitumumab: NSABP FC-7, A Phase Ib Study.
Jacobs, Samuel A; Lee, James J; George, Thomas J; Wade, James L; Stella, Philip J; Wang, Ding; Sama, Ashwin R; Piette, Fanny; Pogue-Geile, Katherine L; Kim, Rim S; Gavin, Patrick G; Lipchik, Corey; Feng, Huichen; Wang, Ying; Finnigan, Melanie; Kiesel, Brian F; Beumer, Jan H; Wolmark, Norman; Lucas, Peter C; Allegra, Carmen J; Srinivasan, Ashok.
Afiliação
  • Jacobs SA; NSABP Foundation, Inc., Pittsburgh, Pennsylvania. Samuel.jacobs@nsabp.org ashok.srinivasan@nsabp.org.
  • Lee JJ; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.
  • George TJ; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Wade JL; UPMC, Pittsburgh, Pennsylvania.
  • Stella PJ; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.
  • Wang D; University of Florida, Gainesville, Florida.
  • Sama AR; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.
  • Piette F; Cancer Care Specialists of Illinois, Decatur, Illinois.
  • Pogue-Geile KL; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.
  • Kim RS; St. Joseph Mercy Health System, Ann Arbor, Michigan.
  • Gavin PG; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.
  • Lipchik C; Henry Ford Cancer Institute, Detroit, Michigan.
  • Feng H; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.
  • Wang Y; Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
  • Finnigan M; International Drug Development Institute (IDDI), Louvain la Neuve, Belgium.
  • Kiesel BF; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.
  • Beumer JH; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.
  • Wolmark N; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.
  • Lucas PC; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.
  • Allegra CJ; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.
  • Srinivasan A; NSABP Foundation, Inc., Pittsburgh, Pennsylvania.
Clin Cancer Res ; 27(6): 1612-1622, 2021 03 15.
Article em En | MEDLINE | ID: mdl-33203645
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Resistencia a Medicamentos Antineoplásicos / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Resistencia a Medicamentos Antineoplásicos / Mutação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article